Expensify launches hybrid 'contextual' AI expense agent; Forwardly announces AI bill pay system; Patriot Software introduces ...

Gyre Therapeutics ("Gyre") (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, ...

ITAT Pune ruled that the late filing of the Form 10B audit report is not fatal to the charitable trust exemption if filed before assessment completion. The court reversed the disallowance of ...

Expensify, Inc. ( ($EXFY) ) has released its Q3 earnings. Here is a breakdown of the information Expensify, Inc. presented to its investors.

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence ...

Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, today announced its operating and financial results ...

Strengthened balance sheet with private placement of up to $100 million to advance CMP-002, a first-in-class treatment for SYNGAP1-related disorders ...

Announced increased focus on type 1 diabetes and in vivo CAR T programsRegulatory interactions increase confidence in moving forward with GMP ...

Elizabeth City city employees and the former city manager in noncompliance for nearly $100,000 in food expenditures, says the ...

Ligand is increasing its 2025 full year financial guidance. The Company now expects total core revenue of $225 million to ...

DHL is using Celonis' process intelligence platform combined with generative AI to automatically screen 100% of employee ...

Please note that the limited information that follows in this press release is not adequate to make an informed investment ...